Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | GAA | P10253 | 3/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17255685 | 0.86 | KDM4E (0.70) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL27920214 | 0.83 | KDM4E (0.66) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL15442541 | 0.83 | KDM4E (0.66) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL17255677 | 0.83 | KDM4E (0.66) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL17255695 | 0.83 | KDM4E (0.66) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL19239922 | 0.81 | TSHR (0.55) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL27938660 | 0.80 | KDM4E (0.62) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL27920192 | 0.80 | KDM4E (0.62) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL27993298 | 0.80 | KDM4E (0.62) | KDM4EGAATSHRHTTCA12 | |
| SCHEMBL2052349 | 0.80 | KDM4E (0.67) | KDM4EGAATSHRCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11712436-B2 | Theranostic test for antifungal treatment of inflammatory diseases | CORNELL UNIVERSITY (US) | 2023-08-01 | — | — | US | claimed |
| US-20200061018-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2020-02-27 | — | — | US | claimed |
| WO-2019190503-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2019-10-03 | — | — | WO | claimed |
| WO-2019150485-A1 | LIQUID AGENT FOR EXTERNAL USE FOR PREVENTION AND TREATMENT OF ONYCHOMYCOSIS | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2019-08-08 | — | — | WO | claimed |
| WO-2019151282-A1 | LIQUID AGENT FOR EXTERNAL USE FOR PREVENTION AND TREATMENT OF ONYCHOMYCOSIS | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2019-08-08 | — | — | WO | claimed |
| US-10123978-B2 | Patch for treating dermatophytosis | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-11-13 | — | — | US | claimed |
| EP-2881114-B1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | MEIJI SEIKA PHARMA CO LTD (JP) | 2018-09-05 | — | — | EP | claimed |
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-07-19 | — | — | US | claimed |
| EP-2669274-B1 | TOPICAL ANTIFUNGAL AGENT | MEIJI SEIKA PHARMA CO LTD (JP) | 2015-11-18 | — | — | EP | claimed |
| CN-103339112-B | Topical antifungal agents | MEIJI SEIKA PHARMA CO.,LTD. (JP) | 2015-08-12 | — | — | CN | claimed |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | NICHIBAN COMPANY LIMITED (JP) | 2015-07-30 | — | — | US | claimed |
| EP-2889031-A1 | ANTITRICHOPHYTOSIS SOLUTION FOR EXTERNAL USE | Meiji Seika Pharma Co., Ltd. (JP) | 2015-07-01 | — | — | EP | claimed |
| EP-2881114-A1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | Meiji Seika Pharma Co., Ltd. (JP) | 2015-06-10 | — | — | EP | claimed |
| CN-104661661-A | External liquid preparation for resisting trichophytosis | MEIJI SEIKA PHARMA CO LTD | 2015-05-27 | — | — | CN | claimed |
| US-8889727-B2 | Topical antifungal agent | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-11-18 | — | — | US | claimed |
| US-20140030209-A1 | TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-01-30 | — | — | US | claimed |
| EP-2669274-A1 | TOPICAL ANTIFUNGAL AGENT | Meiji Seika Pharma Co., Ltd. (JP) | 2013-12-04 | — | — | EP | claimed |
| US-20130317074-A1 | TOPICAL ANTIFUNGAL AGENT | MEIJI SEIKA PHARMA CO., LTD. | 2013-11-28 | — | — | US | claimed |
| CN-103339112-A | Topical antifungal agent | MEIJI SEIKA PHARMA CO LTD | 2013-10-02 | — | — | CN | claimed |
| EP-4746860-A1 | HYDROGEN SULPHIDE FOR TOPICAL TREATMENT OF NAIL INFECTION | KING'S COLLEGE LONDON (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12473310-B2 | Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound | KING'S COLLEGE LONDON (GB) | 2025-11-18 | — | — | US | disclosed |
| WO-2025017299-A1 | HYDROGEN SULPHIDE FOR TOPICAL TREATMENT OF NAIL INFECTION | KING'S COLLEGE LONDON (GB) | 2025-01-23 | — | — | WO | disclosed |
| US-12136317-B2 | Information management system and terminal device | UNIVERSAL ENTERTAINMENT CORPORATION (JP) | 2024-11-05 | — | — | US | disclosed |
| US-20240116959-A1 | VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND | KING'S COLLEGE LONDON (GB) | 2024-04-11 | — | — | US | disclosed |
| EP-4232148-A1 | VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND | King's College London (GB) | 2023-08-30 | — | — | EP | disclosed |
| US-11712436-B2 | Theranostic test for antifungal treatment of inflammatory diseases | CORNELL UNIVERSITY (US) | 2023-08-01 | — | — | US | disclosed |
| US-20220189252-A1 | INFORMATION MANAGEMENT SYSTEM AND TERMINAL DEVICE | UNIVERSAL ENTERTAINMENT CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| WO-2022084669-A1 | VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND | KING'S COLLEGE LONDON (GB) | 2022-04-28 | — | — | WO | disclosed |
| CN-106866737-B | Phosphonic acid derivatives and their use | 南京圣和药物研发有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-20200061018-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2020-02-27 | — | — | US | disclosed |
| US-20200061018-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2020-02-27 | — | — | US | disclosed |
| US-10562858-B2 | Crystalline anti-trichophyton agents and preparation process thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| US-10562858-B2 | Crystalline anti-trichophyton agents and preparation process thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| US-10562858-B2 | Crystalline anti-trichophyton agents and preparation process thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| CN-106573892-B | Crystalline anti-tinea alba bacteria medicine and preparation method thereof | 明治制果药业株式会社 | 2019-10-25 | — | — | CN | disclosed |
| CN-106573892-B | Crystalline anti-tinea alba bacteria medicine and preparation method thereof | 明治制果药业株式会社 | 2019-10-25 | — | — | CN | disclosed |
| WO-2019190503-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2019-10-03 | — | — | WO | disclosed |
| WO-2019190503-A1 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | COVE BIO LLC (US) | 2019-10-03 | — | — | WO | disclosed |
| CN-110218187-A | Crystallinity tinea alba fungi resisting medicine and preparation method thereof | 明治制果药业株式会社 | 2019-09-10 | — | — | CN | disclosed |
| CN-110218187-A | Crystallinity tinea alba fungi resisting medicine and preparation method thereof | 明治制果药业株式会社 | 2019-09-10 | — | — | CN | disclosed |
| WO-2019150485-A1 | LIQUID AGENT FOR EXTERNAL USE FOR PREVENTION AND TREATMENT OF ONYCHOMYCOSIS | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2019-08-08 | — | — | WO | disclosed |
| WO-2019151282-A1 | LIQUID AGENT FOR EXTERNAL USE FOR PREVENTION AND TREATMENT OF ONYCHOMYCOSIS | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2019-08-08 | — | — | WO | disclosed |
| US-10123978-B2 | Patch for treating dermatophytosis | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-11-13 | — | — | US | disclosed |
| US-10123978-B2 | Patch for treating dermatophytosis | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-11-13 | — | — | US | disclosed |
| EP-2881114-B1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | MEIJI SEIKA PHARMA CO LTD (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20170233346-A1 | CRYSTALLINE ANTI-TRICHOPHYTON AGENTS AND PREPARATION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170233346-A1 | CRYSTALLINE ANTI-TRICHOPHYTON AGENTS AND PREPARATION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170233346-A1 | CRYSTALLINE ANTI-TRICHOPHYTON AGENTS AND PREPARATION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| US-20170233346-A1 | CRYSTALLINE ANTI-TRICHOPHYTON AGENTS AND PREPARATION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2017-08-17 | — | — | US | disclosed |
| WO-2017133517-A1 | PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF | 四川海思科制药有限公司 | 2017-08-10 | — | — | WO | disclosed |
| EP-3190105-A1 | CRYSTALLINE ANTI-TRICHOPHYTON DRUG AND METHOD FOR PRODUCING SAME | Meiji Seika Pharma Co., Ltd. (JP) | 2017-07-12 | — | — | EP | disclosed |
| EP-3190105-A1 | CRYSTALLINE ANTI-TRICHOPHYTON DRUG AND METHOD FOR PRODUCING SAME | Meiji Seika Pharma Co., Ltd. (JP) | 2017-07-12 | — | — | EP | disclosed |
| EP-3190105-A1 | CRYSTALLINE ANTI-TRICHOPHYTON DRUG AND METHOD FOR PRODUCING SAME | Meiji Seika Pharma Co., Ltd. (JP) | 2017-07-12 | — | — | EP | disclosed |
| CN-106866737-A | Phosphonate derivative and its application | 南京圣和药业股份有限公司 | 2017-06-20 | — | — | CN | disclosed |
| CN-106573892-A | Crystalline anti-tinea alba bacteria medicine and preparation method thereof | 明治制果药业株式会社 | 2017-04-19 | — | — | CN | disclosed |
| CN-106573892-A | Crystalline anti-tinea alba bacteria medicine and preparation method thereof | 明治制果药业株式会社 | 2017-04-19 | — | — | CN | disclosed |
| WO-2016024602-A1 | CRYSTALLINE ANTI-TRICHOPHYTON DRUG AND METHOD FOR PRODUCING SAME | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2016-02-18 | — | — | WO | disclosed |
| WO-2016024602-A1 | CRYSTALLINE ANTI-TRICHOPHYTON DRUG AND METHOD FOR PRODUCING SAME | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2016-02-18 | — | — | WO | disclosed |
| EP-2669274-B1 | TOPICAL ANTIFUNGAL AGENT | MEIJI SEIKA PHARMA CO LTD (JP) | 2015-11-18 | — | — | EP | disclosed |
| CN-103339112-B | Topical antifungal agents | MEIJI SEIKA PHARMA CO.,LTD. (JP) | 2015-08-12 | — | — | CN | disclosed |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | NICHIBAN COMPANY LIMITED (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-2889031-A1 | ANTITRICHOPHYTOSIS SOLUTION FOR EXTERNAL USE | Meiji Seika Pharma Co., Ltd. (JP) | 2015-07-01 | — | — | EP | disclosed |
| EP-2881114-A1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | Meiji Seika Pharma Co., Ltd. (JP) | 2015-06-10 | — | — | EP | disclosed |
| CN-104661661-A | External liquid preparation for resisting trichophytosis | MEIJI SEIKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| US-8889727-B2 | Topical antifungal agent | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-20140030209-A1 | TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-01-30 | — | — | US | disclosed |
| EP-2669274-A1 | TOPICAL ANTIFUNGAL AGENT | Meiji Seika Pharma Co., Ltd. (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20130317074-A1 | TOPICAL ANTIFUNGAL AGENT | MEIJI SEIKA PHARMA CO., LTD. | 2013-11-28 | — | — | US | disclosed |
| CN-103339112-A | Topical antifungal agent | MEIJI SEIKA PHARMA CO LTD | 2013-10-02 | — | — | CN | disclosed |
| CN-103339112-A | Topical antifungal agent | MEIJI SEIKA PHARMA CO LTD | 2013-10-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | DPM1, KRT18, LCP1 | KDM4E 159/4885GAA 4547/4885TSHR 4300/4885 |
| US-10123978-B2 | Patch for treating dermatophytosis | DPM1, KRT18, LCP1 | KDM4E 159/4885GAA 4547/4885TSHR 4300/4885 |
| US-12473310-B2 | Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound | VDR, CYP24A1, CYP2R1 | KDM4E 2494/4885GAA 2644/4885TSHR 1713/4885 |
| US-10562858-B2 | Crystalline anti-trichophyton agents and preparation process thereof | ZP1, TBKBP1, MITF | KDM4E 308/4885GAA 1363/4885TSHR 880/4885 |
| US-20170233346-A1 | CRYSTALLINE ANTI-TRICHOPHYTON AGENTS AND PREPARATION PROCESS THEREOF | ZP1, TBKBP1, MITF | KDM4E 308/4885GAA 1363/4885TSHR 880/4885 |
| US-20130317074-A1 | TOPICAL ANTIFUNGAL AGENT | DPM1, ERG28, PIK3C3 | KDM4E 824/4885GAA 435/4885TSHR 4729/4885 |
| US-20140030209-A1 | TOPICAL LIQUID AGENT FOR THE TREATMENT OF DERMATOPHYTOSIS | POLR1C, CUTA, C1R | KDM4E 3884/4885GAA 4050/4885TSHR 317/4885 |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | CUTA, NACA, POLR1C | KDM4E 1955/4885GAA 4680/4885TSHR 795/4885 |
| US-20240116959-A1 | VITAMIN D3 PHOSPHATE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHODS FOR PREPARING THE COMPOUND | VDR, CYP24A1, CYP2R1 | KDM4E 2494/4885GAA 2644/4885TSHR 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.